- Home
- XFOR vs CFFI Comparison
XFOR vs CFFI Comparison
Compare XFOR & CFFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XFOR | CFFI |
|---|---|---|
| Founded | 2014 | 1927 |
| Country | United States | United States |
| Employees | 143 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 276.3M | 258.7M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | XFOR | CFFI |
|---|---|---|
| Price | $3.37 | $74.79 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $28.50 | N/A |
| AVG Volume (30 Days) | ★ 548.3K | 2.2K |
| Earning Date | 01-01-0001 | 04-28-2026 |
| Dividend Yield | N/A | ★ 2.53% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 6.22 |
| Revenue | N/A | ★ $127,313,000.00 |
| Revenue This Year | $1,263.94 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.73 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.17 | $53.14 |
| 52 Week High | $6.63 | $80.99 |
Technical Indicators
Market Signals| Indicator | XFOR | CFFI |
|---|---|---|
| Relative Strength Index (RSI) | 47.09 | 48.30 |
| Support Level | $3.18 | $66.92 |
| Resistance Level | $3.45 | $80.01 |
| Average True Range (ATR) | 0.24 | 1.38 |
| MACD | 0.02 | -0.57 |
| Stochastic Oscillator | 58.11 | 31.99 |
Price Performance
Historical ComparisonAbout XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
About CFFI C&F Financial Corporation
C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum of its revenue from the Community Banking segment.